Delivery Order SPE2DB24D2100-SPE2DB25FBAHA
Award Date
10/9/24
Potential Completion Date
10/10/24
Potential Value
$48K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $6,645.44 firm-fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 15 MG TABLET medication. The contract has an ultimate completion date of October 22, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 30 MG TABLET UU 30S. The contract has a ceiling value of $38,667.19 and a period of performance ending on July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a $69,691.00 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of RINVOQ ER 45 MG TABLET UU 28S. This is a delivery order issued under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025 for the provision of a comprehensive range...
The U.S. Defense Logistics Agency (DLA) awarded a $40,807.49 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide RINVOQ ER 45 MG TABLET UU 28S. This contract has an ultimate completion date of March 14, 2025 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division. The $6,682.71 contract is for the supply of RINVOQ ER 15 MG TABLET in 30 count units, with a completion date of May 10, 2024. This award is a task order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
The U.S. Department of Defense (DOD) Defense Logistics Agency (DLA) awarded a $14,048.42 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4566803438 - RINVOQ ER 15 MG TABLET UU 30S. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a comprehensive vehicle for supplying a range of pharmaceutical...
The Defense Logistics Agency (DLA) has awarded a $8,241.24 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division to provide 4564530227 RINVOQ ER 15 MG TABLET UU 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense (DoD)...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 15 MG TABLET in the amount of $6,467.69. The contract has an ultimate completion date of March 17, 2025 and was awarded on March 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $45,115.65 firm fixed price delivery order is for the supply of RINVOQ ER 30 MG TABLET, a prescription medication. The contract has an ultimate completion date of September 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $7,275.16, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S. The contract has a period of performance through March 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves as the...